SUPPORT PROGRAMME FOR PATIENTS RECEIVING IMRALDI OR BENEPALI THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERS: 12-MONTH PERSISTENCE

被引：0
|
作者：
Clark, Andrew [1 ]
Shering, Teresa [1 ]
Addison, Janet [2 ]
机构：
[1] Biogen Idec Ltd, Maidenhead, Berks, England
[2] Biogen Idec Ltd, Clin Res, Maidenhead, Berks, England
来源：
RHEUMATOLOGY | 2024年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P067
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Systematic Review Of Interferon-Gamma Release Assays For Detection Of Latent Tuberculosis Infection In Patients With Immune-Mediated Inflammatory Disorders
    Smith, R. M.
    Weiss, J.
    Pai, M.
    Steingart, K.
    Winthrop, K.
    Metcalfe, J. Z.
    Hopewell, P. C.
    Cattamanchi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [42] Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases
    José M. Ramos
    Mar Masiá
    Juan C. Rodríguez
    Cristina López
    Sergio Padilla
    Catalina Robledano
    Francisco J. Navarro-Blasco
    Jaime Matarredona
    Mariana F. García-Sepulcre
    Félix Gutiérrez
    Clinical and Experimental Medicine, 2013, 13 : 177 - 186
  • [43] Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases
    Le Tilly, Olivier
    Paintaud, Gilles
    Ternant, David
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (11): : 1069 - 1069
  • [44] Therapeutic Drug Monitoring Compared to Standard Infliximab Therapy in Patients with Immune-mediated Inflammatory Diseases: A Randomized Controlled Trial
    Syversen, Silje Watterdal
    Goll, Guro
    Jorgensen, Kristin
    Brun, Marthe
    Sandanger, Oystein
    Hammersboen, Kristin
    Sexton, Joseph
    Olsen, Inge
    Gehin, Johanna
    Warren, David
    Klaasen, Rolf Anton
    Bruun, Trude
    Ljosa, Maud Kristine
    Haugen, Anne
    Njalla, Rune
    Michelsen, Brigitte
    Zettel, Camilla
    Bragenes, Yngvill
    Skorpe, Svanaug
    Strand, Eldri
    Mielnik, Pawel
    Mork, Cato
    Kvien, Tore
    Jahnsen, Jorgen
    Bolstad, Nils
    Haavardsholm, Espen
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4080 - 4082
  • [45] Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases
    Ramos, Jose M.
    Masia, Mar
    Rodriguez, Juan C.
    Lopez, Cristina
    Padilla, Sergio
    Robledano, Catalina
    Navarro-Blasco, Francisco J.
    Matarredona, Jaime
    Garcia-Sepulcre, Mariana F.
    Gutierrez, Felix
    CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 13 (03) : 177 - 186
  • [46] INDETERMINATE IGRA RESULTS PRIOR TO ANTI-TNF THERAPY: STABLE STATE TESTING MAY BE IMPORTANT FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERS
    Ibrahim, W.
    Abunga, Y.
    Mamo, J.
    Beck, S.
    Brij, S. O.
    THORAX, 2016, 71 : A144 - A145
  • [47] PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis
    Bouhnik, Yoram
    Fautrel, Bruno
    Beaugerie, Laurent
    Pelletier, Anne-Laure
    Martinez-Vinson, Christine
    Freudensprung, Ulrich
    Brigui, Amira
    Addison, Janet
    PERFUSE investigators
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [48] 12-month outcomes after voretigene neparvovec gene therapy in paediatric patients with RPE65-mediated inherited retinal dystrophy
    Daruich, Alejandra
    Rateaux, Maxence
    Batte, Emilie
    de Vergnes, Nathalie
    Valleix, Sophie
    Robert, Matthieu P.
    Gignac, Dominique Bremond
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024,
  • [49] THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-COV-2 VACCINES IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES USING IMMUNOSUPPRESSIVE THERAPY, COMPARED TO HEALTHY CONTROLS
    Christensen, I. Egeland
    Jyssum, I.
    Tveter, A. T.
    Sexton, J.
    Tran, T. T.
    Mjaaland, S.
    Kro, G. B.
    Kvien, T. K.
    Worren, D.
    Jahnsen, J.
    Munthe, L. A.
    Haavardsholm, E.
    Vaage, J. T.
    Grodeland, G.
    Lund-Johansen, F.
    Jorgensen, K. K.
    Syversen, S. W.
    Goll, G. L.
    Provan, S. Aarrestad
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 116 - 117
  • [50] How should we best manage patients with immune-mediated inflammatory disease on immunosuppressant therapy during the 'swine flu' pandemic?
    Mangat, P.
    Abraham, S.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2011, 104 (03) : 269 - 270
12345